SUPPORT FOR THE PRECLINICAL DEVELOPMENT OF EIF4A INHIBITORS ROCAGLAMIDE AND DIDESMETHYLROCAGLAMIDE. (TOXICIOLOGY SERVICES TO SUPPORT PRECLINICAL DRUG

NIH RePORTER · NIH · N01 · $588,615 · view on reporter.nih.gov ↗

Abstract

Support for the Preclinical Development of eIF4A inhibitors Rocaglamide and Didesmethylrocaglamide

Key facts

NIH application ID: 10281213
Project number: 261201600015I-0-759102000001-1
Recipient: IIT RESEARCH INSTITUTE
Principal Investigator: DAVID MCCORMICK
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $588,615
Award type: —
Project period: 2020-09-23 → 2021-09-22